简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2020-09-16 17:40 C3.ai Launches C3.ai COVID-19 Grand Challenge
2020-09-16 16:15 Takeda Opens New R&D Cell Therapy Manufacturing Facility to Support Expansion of Next-Generation Clinical Programs
2020-09-16 15:22 Takeda to Divest TachoSil® to Corza Health for €350 Million
2020-09-16 10:18 New Optimum® Class VI Dispensing Components Provide Assurance to Medical Manufactures
2020-09-15 19:14 Members of Project Management Institute Community Take the TED Mainstage to Share Big, Bold, Creative Ideas at New Virtual Event
2020-09-15 13:06 Mitsui Chemicals’ UNISTOLE™ Adopted by Siemens as Coating Agent for 3D-Printed Medical-Grade Face Shields
2020-09-15 09:35 Phase II trial results demonstrated improvement in cognition with BI 425809 in adult patients with schizophrenia
2020-09-14 16:23 Public Wants Greater Focus on Science-Based Decision-Making Says New International Survey from Philip Morris International
2020-09-14 13:42 New Study: Hand Dryers Equally Hygienic to Paper Towels for Drying Hands
2020-09-14 09:00 Hong Kong Laureate Forum: Calling Outstanding Young Scientists in Astronomy, Life Science and Medicine, and Mathematical Sciences!
2020-09-14 08:52 Boehringer Ingelheim and Click Therapeutics Enter into Collaboration to Develop and Commercialize CT-155, a Novel Prescription Digital Therapeutic to Aid in the Treatment of Schizophrenia
2020-09-11 16:33 Ascend Expands Antimicrobial Acteev™ Technology Into Finished Goods Line to Combat COVID-19 Spread
2020-09-11 14:45 Ascend Performance Materials Announces Price Increase for Intermediate Materials
2020-09-11 10:05 Mary Kay Inc. COVID-19 Support Efforts Target Disproportionately Effected Native American Populations Through the Indian Health Service Network
2020-09-11 09:56 Carrier/EMSI Facilities Become First WELL Health-Safety Rated Workplaces in China
2020-09-11 09:54 Boehringer Ingelheim Advances Novel Bi-specific TRAILR2/CDH17 Antibody to Phase 1 Clinical Trial for Patients Living with Gastrointestinal Cancers
2020-09-10 16:30 Takeda Announces Results from Phase 3 Clinical Trial Evaluating NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma
2020-09-09 18:48 Pandemic Spotlights the Urgent Need for a National Patient Safety Board
2020-09-09 18:00 Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the Trial of APR003, an Orally-Administered Gastrointestinal/Liver-Targeted TLR7 Agonist for Treatment of Advanced Colorectal Cancer (CRC) with Malignant Liver Lesions
2020-09-09 16:12 Invivoscribe Appoints Loui Madakamutil to Lead Its Therapeutics Division as Chief Scientific Officer

Business Wire Weibo

Press Releases

Latest Releases